Insider Transactions in Q1 2025 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
895
-1.79%
|
$94,870
$106.11 P/Share
|
|
Feb 14
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,850
+3.56%
|
-
|
|
Feb 14
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,534
-7.33%
|
$162,604
$106.11 P/Share
|
|
Feb 14
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
3,172
+13.16%
|
-
|
|
Feb 14
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-1.11%
|
$210,940
$106.11 P/Share
|
|
Feb 14
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,362
+2.38%
|
-
|
|
Feb 14
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,990
-0.49%
|
$846,940
$106.11 P/Share
|
|
Feb 14
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,524
+1.0%
|
-
|
|
Feb 14
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,266
-3.9%
|
$134,196
$106.11 P/Share
|
|
Feb 14
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,776
+7.87%
|
-
|
|
Feb 14
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
38
-2.3%
|
$4,028
$106.11 P/Share
|
|
Feb 14
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
106
+6.04%
|
-
|
|
Feb 14
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
330
-2.41%
|
$34,980
$106.11 P/Share
|
|
Feb 14
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,123
+7.58%
|
-
|
|
Feb 14
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
1,201
-4.51%
|
$127,306
$106.31 P/Share
|
|
Feb 14
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
965
-3.5%
|
$102,290
$106.11 P/Share
|
|
Feb 14
2025
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,115
+7.12%
|
-
|
|
Feb 14
2025
|
Emily Woodworth SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
315
-8.15%
|
$33,390
$106.11 P/Share
|
|
Feb 14
2025
|
Emily Woodworth SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
661
+14.6%
|
-
|
|
Feb 12
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
950
-5.08%
|
$99,750
$105.77 P/Share
|
|
Feb 12
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,692
+12.58%
|
-
|
|
Feb 12
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,579
-0.9%
|
$165,795
$105.77 P/Share
|
|
Feb 12
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,462
+1.93%
|
-
|
|
Feb 12
2025
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,626
-0.41%
|
$695,730
$105.77 P/Share
|
|
Feb 12
2025
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,704
+0.83%
|
-
|
|
Feb 12
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
868
-2.84%
|
$91,140
$105.77 P/Share
|
|
Feb 12
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,115
+6.47%
|
-
|
|
Feb 12
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
23
-1.47%
|
$2,415
$105.77 P/Share
|
|
Feb 12
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
65
+3.98%
|
-
|
|
Feb 12
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
338
-2.62%
|
$35,490
$105.77 P/Share
|
|
Feb 12
2025
|
Miriam O'Sullivan SVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
961
+6.92%
|
-
|
|
Feb 12
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
530
-2.04%
|
$55,650
$105.77 P/Share
|
|
Feb 12
2025
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,731
+6.24%
|
-
|
|
Feb 12
2025
|
Emily Woodworth SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
231
-6.72%
|
$24,255
$105.77 P/Share
|
|
Feb 12
2025
|
Emily Woodworth SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
480
+12.25%
|
-
|
|
Feb 12
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,767
-0.72%
|
$185,535
$105.77 P/Share
|
|
Feb 12
2025
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,741
+3.51%
|
$149,928
$8.16 P/Share
|
|
Feb 12
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
424
-0.87%
|
$44,520
$105.77 P/Share
|
|
Feb 12
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,442
+2.88%
|
-
|
|
Feb 12
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
15,087
-5.88%
|
$1,584,135
$105.07 P/Share
|
|
Feb 12
2025
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
13,022
-31.4%
|
$1,367,310
$105.06 P/Share
|
|
Feb 12
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
6,389
-20.82%
|
$670,845
$105.06 P/Share
|
|
Feb 12
2025
|
John Bradley Sorenson EVP, Global Operations |
SELL
Bona fide gift
|
Direct |
2,156
-6.57%
|
-
|
|
Feb 11
2025
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,414
-6.37%
|
$1,723,470
$105.98 P/Share
|
|
Feb 11
2025
|
Daniel J. Brennan EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
33,944
+11.63%
|
-
|
|
Feb 11
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,350
-11.85%
|
$666,750
$105.98 P/Share
|
|
Feb 11
2025
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
14,708
+21.54%
|
-
|
|
Feb 11
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
9,847
-38.07%
|
$1,033,935
$105.98 P/Share
|
|
Feb 11
2025
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Grant, award, or other acquisition
|
Direct |
20,366
+44.05%
|
-
|
|
Feb 11
2025
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
14,447
-7.71%
|
$1,516,935
$105.98 P/Share
|